Biomedical Engineering Reference
In-Depth Information
Ciavarella, S., Milano, A., Dammacco, F. & Silvestris, F. (2010) Targeted therapies in cancer.
BioDrugs
, 24, 77-88.
Clayton, R., Ohagen, A., Goethals, O., Smets, A., Van Loock, M., Michiels, L., Kennedy-
Johnston, E., Cunningham, M., Jiang, H., Bola, S., Gutshall, L., Gunn, G., Del Vecchio, A.,
Sarisky, R., Hallenberger, S. & Hertogs, K. (2007) Binding kinetics, uptake and intracellular
accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1
infected cells.
J Virol Methods
, 139, 17-23.
Clayton, R., Ohagen, A., Nicol, F., Del Vecchio, A. M., Jonckers, T. H., Goethals, O., Van Loock,
M., Michiels, L., Grigsby, J., Xu, Z., Zhang, Y. P., Gutshall, L. L., Cunningham, M., Jiang, H.,
Bola, S., Sarisky, R. T. & Hertogs, K. (2009) Sustained and specific in vitro inhibition of
HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
Antiviral
Res
, 84, 142-9.
Cobos, E. J., Entrena, J. M., Nieto, F. R., Cendan, C. M. & Del Pozo, E. (2008) Pharmacology and
therapeutic potential of sigma(1) receptor ligands.
Curr Neuropharmacol
, 6, 344-66.
Cohen, C., Forzan, M., Sproat, B., Pantophlet, R., McGowan, I., Burton, D. & James, W. (2008)
An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5
binding site.
Virology
, 381, 46-54.
Connor, J. & Huang, L. (1986) pH-sensitive immunoliposomes as an efficient and target-specific
carrier for antitumor drugs.
Cancer Res
, 46, 3431-5.
Cook, S. E., Park, I. K., Kim, E. M., Jeong, H. J., Park, T. G., Choi, Y. J., Akaike, T. & Cho, C. S.
(2005) Galactosylated polyethylenimine-graft-poly(vinyl pyrrolidone) as a hepatocyte-targeting
gene carrier.
J Control Release
, 105, 151-63.
Dakappagari, N., Maruyama, T., Renshaw, M., Tacken, P., Figdor, C., Torensma, R., Wild, M. A.,
Wu, D., Bowdish, K. & Kretz-Rommel, A. (2006) Internalizing antibodies to the C-type lectins,
L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human den-
dritic cells for the induction of T cell responses.
J Immunol
, 176, 426-40.
Daniels, T. R., Delgado, T., Helguera, G. & Penichet, M. L. (2006) The transferrin receptor part
II: targeted delivery of therapeutic agents into cancer cells.
Clin Immunol
, 121, 159-76.
Dassie, J. P., Liu, X. Y., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R.,
Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., 2nd & Giangrande, P. H. (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of
PSMA-expressing tumors.
Nat Biotechnol
, 27, 839-49.
Davis, M. E. (2009) The first targeted delivery of siRNA in humans via a self-assembling, cyclo-
dextrin polymer-based nanoparticle: from concept to clinic.
Mol Pharm
, 6, 659-68.
Davis, M. E., Zuckerman, J. E., Choi, C. H., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y.,
Heidel, J. D. & Ribas, A. (2010) Evidence of RNAi in humans from systemically administered
siRNA via targeted nanoparticles.
Nature
, 464, 1067-70.
Dey, A. K., Khati, M., Tang, M., Wyatt, R., Lea, S. M. & James, W. (2005) An aptamer that neu-
tralizes R5 strains of human immunodeficiency virus type 1 blocks gp120-CCR5 interaction.
J Virol
, 79, 13806-10.
Dharap, S. S., Qiu, B., Williams, G. C., Sinko, P., Stein, S. & Minko, T. (2003) Molecular targeting
of drug delivery systems to ovarian cancer by BH3 and LHRH peptides.
J Control Release
,
91, 61-73.
Dharap, S. S., Wang, Y., Chandna, P., Khandare, J. J., Qiu, B., Gunaseelan, S., Sinko, P. J., Stein,
S., Farmanfarmaian, A. & Minko, T. (2005) Tumor-specific targeting of an anticancer drug
delivery system by LHRH peptide.
Proc Natl Acad Sci U S A
, 102, 12962-7.
Duthie, S. J. (2001) Folic-acid-mediated inhibition of human colon-cancer cell growth.
Nutrition
,
17, 736-7.
Dutta, T., Agashe, H. B., Garg, M., Balakrishnan, P., Kabra, M. & Jain, N. K. (2007) Poly (pro-
pyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/
macrophages in vitro.
J Drug Target
, 15, 89-98.
Dutta, T. & Jain, N. K. (2007) Targeting potential and anti-HIV activity of lamivudine loaded
mannosylated poly (propyleneimine) dendrimer.
Biochim Biophys Acta
, 1770, 681-6.
Search WWH ::
Custom Search